FI

Faiza Iffat

Active Director Director DIN 07278571
DIN 07278571 First appointment Sep 2015 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2015
Shareholding value •••• Premium profile

About Faiza Iffat

Data last updated:

Faiza Iffat is a Director at Iffat Pharmaceuticals Private Limited (since 2015). The company operates in Chemicals. Iffat Pharmaceuticals Private Limited reported revenue of ₹15.5 Lakh (FY 2024).

DIN 07278571
Primary Designation Director
Industry Chemicals
First Appointment 18 Sep 2015
Oldest Company Age 11 yrs
Largest company Iffat Pharmaceuticals Private Limited · ₹15.5 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director18 Sep 20152015₹15.5 Lakh (FY 2024)Active

Board colleagues of Faiza Iffat

NameDINCompanyDesignation
Nesar Ahmad07278580Iffat Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Iffat Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Faiza Iffat

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Faiza Iffat

Faiza Iffat currently holds 1 directorship: Iffat Pharmaceuticals Private Limited (Director, since 18 Sep 2015, revenue ₹15.5 Lakh (FY 2024)).

Faiza Iffat was first appointed on 18 Sep 2015 as Director at Iffat Pharmaceuticals Private Limited.

The current boards of Faiza Iffat's companies include Nesar Ahmad (Iffat Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available